A Case of Nasal/Paranasal Metastatic Renal Cell Carcinoma with VEGF Targeted Therapy
-
- Kumai Takumi
- Asahikawa Medical University
-
- Takahara Miki
- Asahikawa Medical University
-
- Yoshida Saeko
- Asahikawa Medical University
-
- Nagato Toshihiro
- Asahikawa Medical University
-
- Hayashi Tatsuya
- Asahikawa Medical University
-
- Harabuchi Yasuaki
- Asahikawa Medical University
Bibliographic Information
- Other Title
-
- 分子標的薬が奏功した腎癌鼻副鼻腔転移例
- 臨床 分子標的薬が奏功した腎癌鼻副鼻腔転移例
- リンショウ ブンシ ヒョウテキヤク ガ ソウコウ シタ ジンガン ビ フクビコウ テンイレイ
Search this article
Abstract
Renal cell carcinoma (RCC) occasionally metastasizes to a variety of regions including bone and liver, but nasal and paranasal sinal metastases are rare. No standard treatment currently exists, because of the small number of cases, so treatment varies for each patient. Sorafenib is a novel small molecular inhibitor of several kinases for malignancy, especially for RCC and hepatocellular carcinoma. We report herein on a case of nasal and paranasal metastatic RCC treated with VEGF targeted therapy (sorafenib) and radiotherapy.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 106 (5), 423-429, 2013
The Society of Practical Otolaryngology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204273012096
-
- NII Article ID
- 10031166756
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 024650788
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- IRDB
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed
